Discover key insights from InterCure Ltd.'s February 2025 6-K report, highlighting leadership transition as Ehud Barak steps down and financing completion for future growth.
Intercure Ltd. submits Form 6-K detailing December 30, 2024 AGM outcomes. All 5 shareholder proposals approved, ensuring compliance with SEC regulations.
Explore InterCure Ltd.'s December 2024 financial report. Key details on the Extraordinary General Meeting and voting procedures for shareholders included.
Explore InterCure Ltd.'s latest financial report detailing NIS 66M funding, private placement, and strategic growth opportunities.